Dallas
,
US
14 - 17 October 2023
Obesity Week (OW 2023)
Presentation schedule and materials
Sunday, 15 October 2023
11:45
- 13:15
CDT
Poster-060
POSTER
Perceived Impact of Obesity Among Adolescents Living With Obesity: Effect on Perceptions/Behaviors
Martín Toro-Ramos1; Louise A. Baur2; Abdullah Bereket3; Bassam Bin-Abbas4; Walter Chen5; Fernando Fernández-Aranda6; Nayely Garibay Nieto7; Jason C.G. Halford8; Juan Pedro López Siguero9; Claudio Maffeis10; Vicki Mooney11; Cynthia Karenina Osorto12; Ricardo Reynoso13; Young-Jun Rhie14
11:45
- 13:15
CDT
Poster-046
POSTER
Understanding Barriers to Weight Management Journeys of People with Obesity in Urban India: A Qualitative Study
Neeta Deshpande1; Mariana Mercado Garcia2; Swaroop Hassan Suresh3; Maya Sharma3
11:45
- 13:15
CDT
Poster-059
POSTER
Once-daily Oral Semaglutide 50 mg Improves Physical Functioning in the OASIS 1 Trial
Domenica Rubino1; Thomas Holst-Hansen2; Tobias Karlsson2; Kirsi H. Pietiläinen3; Andrea Traina4; Sean Wharton5; Thomas Wadden6
11:45
- 13:15
CDT
Poster-096
POSTER
Obesity and ASCVD/ASCVD Risk in Patients with Type 2 Diabetes across the Middle East and Africa
Gourav Yadav1; Samir H. Assaad-Khalil2; Fatheya Alawadi3; Wael Almahmeed4; Naji Alamuddin5; Hessa Alkandari6; Tarhan Çınar1; Jihad Haddad7; Lise Lotte N. Husemoen8; Landman Lombard9; Rayaz A. Malik10; Mary Ngome1; Hani Sabbour4; Sam Salek11; Subodh Verma12
Monday, 16 October 2023
09:00
- 09:15
CDT
O-068
ORAL PRESENTATION
Semaglutide 2.4 mg in People With or Without Antidepressants at Baseline: A Post-Hoc Analysis
Robert Kushner1; Anders Fink-Jensen2; Ofir Frenkel3; Bryan Goldman3; Barbara McGowan4; Maria Overvad3; Thomas Wadden5
10:00
- 10:15
CDT
O-052
ORAL PRESENTATION
Characteristics and Obesity Care Pathway for Individuals Living with Obesity in Ontario, Canada
1Sean Wharton; 2Adel Belloum; 3Artis Luguzis; 4Maria Eberg; 5Atif Kukaswadia; 5Calum S. Neish; 6Silvia Capucci; 6Anette Varbo; 6Camilla S. Morgen
11:45
- 13:15
CDT
Poster-396
POSTER
Health and Cost Trajectories in People with Body Mass Index Progression: A UK Database Study
Andrew Thompson1,2; Sara Holloway1; Silvia Capucci3
11:45
- 13:15
CDT
Poster-320
POSTER
Once-Daily Oral Semaglutide 50 mg Improves Cardiovascular Risk Factors in Overweight/Obesity in the OASIS 1 Trial
W. Timothy Garvey1; Thomas Holst-Hansen2; Tobias Karlsson2; Filip K. Knop3,5; Naveen Rathor2; Domenica Rubino6; Julio Rosenstock7
11:45
- 13:15
CDT
Poster-327
POSTER
Real-world effectiveness of semaglutide 2.4 mg in patients with and without depressive disorders
Aleksandrina Ruseva1; Wojciech Michalak1; Zhenxiang Zhao1; Bríain Ó Hartaigh1; Devika Umashanker2; Anthony Fabricatore1
11:45
- 13:15
CDT
Poster-397
POSTER
Body Mass Index Progression Over 8 Years in People Living with Overweight or Obesity in the UK
Andrew Thompson1,2; Sara Holloway1; Silvia Capucci3
11:45
- 13:15
CDT
Poster-242
POSTER
Estimated Growth of the Clinical and Economic Burden of Obesity in the U.S. Over the Next 5 Years
Joshua Toliver1; Mads Faurby1; Volker Schnecke2; Laura Rizkallah2
11:45
- 13:15
CDT
Poster-280
POSTER
Impact of Semaglutide 2.4 mg on Reducing Health Inequality in the US: A Modeling Study
Joshua Toliver1; Mads Faurby1; Jason Shafrin2; Jaehong Kim2; Sanjana Muthukrishnan2; Sean D. Sullivan3,4
Tuesday, 17 October 2023
11:00
- 11:15
CDT
O-086
ORAL PRESENTATION
Effect of Oral Semaglutide 50 mg on Energy Intake, Appetite, Control of Eating, and Gastric Emptying
Maria B. N. Gabe1; Astrid Breitschaft2; Filip K. Knop3,4,5; Morten R. Hansen1; Katrine Kirkeby1; Naveen Rathor1; Charlotte L. Adrian1
11:15
- 11:30
CDT
O-087
ORAL PRESENTATION
Association between Weight Loss and Fecundity among Women with Overweight or Obesity: A Cohort Study using UK Real World Data
Maximiliane Verfürden1; Volker Schnecke1; Eva Winning-Lehmann1; Shweta Uppal1; Kasper Sommer1; Adam Balen2
11:30
- 11:45
CDT
O-088
ORAL PRESENTATION
Impact of Oral Semaglutide 50 mg on PreDiabetes According to Weight Loss Category: OASIS 1 Trial Subanalysis
Julio Rosenstock1; Juan Frias2; W. Timothy Garvey3; Thomas Holst-Hansen4; Anders R. Rinnov4; Andrea Traina5; Filip K. Knop6,7,8
11:45
- 13:15
CDT
Poster-243
POSTER
The Value of 15% Weight Loss in a U.S. Real World Data Cohort of Individuals Living with Obesity
Joshua Toliver1; Mads Faurby1; Volker Schnecke2; Laura Rizkallah2
11:45
- 13:15
CDT
Poster-426
POSTER
Estimating Prevalence & Incidence of Obesity-Related Comorbidities: A Large US Real World Population
Jayashri Desai1; Zhenxiang Zhao1; Wojciech Michalak1; Briain O Hartaigh1; Anthony Fabricatore1; Cynthia Saiontz-Martinez2; Sariya Udayachalerm2; Firas Dabbous2
11:45
- 13:15
CDT
Poster-547
POSTER
ACTION-China: Attitudes About Obesity Among People Living with Obesity and Healthcare Professionals
Linong Ji1; Yiming Mu2; Cuiqing Chang3; Huali Wang4; Di Zhao5; Dongmei Liu5; Zewei Shen5; Wei Chen6
11:45
- 13:15
CDT
Poster-494
POSTER
Effect of semaglutide 2.4 mg on use of antihypertensive and lipid lowering treatment in STEP trials
Michael G. Knight1; Kasper Adelborg2; Jennifer N. Clements3; Aske Thorn Iversen2; Peter Nørkjær Laursen2; Beverly Tchang4; Andrea Traina5
11:45
- 13:15
CDT
Poster-536
POSTER
The Healthcare Costs of People Living with Obesity in Ontario, Canada: A Real-World Study
1Sean Wharton; 2Maria Luckevich; 3Artis Luguzis; 4Maria Eberg; 5Atif Kukaswadia; 5Calum S. Neish; 6Silvia Capucci; 6Anette Varbo; 6Camilla S. Morgen
Keywords